Sep 2026· Stanzaleaf International Journal of Multidisciplinary Studies· 0 citations· 10 references
TL;DR
This review highlights current understanding of the epidemiology, pathophysiology, diagnostic criteria, mechanisms of infertility due to PCOS, and mechanisms of infertility due to PCOS, and management of PCOS patients.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder in women of reproductive age and a major cause of anovulatory infertility around the world. It is a heterogeneous disorder characterised by chronic oligo- or anovulation, clinical and/or biochemical hyperandrogenism, and polycystic ovarian morphology, often complicated by insulin resistance and obesity. This review highlights current understanding of the epidemiology, pathophysiology, diagnostic criteria, mechanisms of infertility due to PCOS, and management of PCOS patients. Due to significant inter-observer variability in ultrasonography assessment of the polycystic ovarian morphology, more and more research work is being done in using deep learning (DL) algorithms such as convolutional neural networks (CNN) and DL-based architecture including InceptionV3, ResNet, VGG16, and DenseNet to automatically diagnose the polycystic ovarian morphology and predict PCOS risk from clinical and hormonal data . In this review we discuss DL architectures used in studies, the datasets, their performances, and limitations, and future directions of using artificial intelligence in infertility in PCOS.
The evidence projects a diagnostic shift toward reproducible, multimodal, and phenotype-sensitive PCOS detection, and integration of AI-based pipelines when integrated with imaging morphology, hormonal data, and metabolic markers offers significant opportunities for equitable, early-stage identification across diverse...
Aman Golani, Soumi Ray· International Journal of Wom...· 0 citations
AI-based methods present enormous potential to revolutionise the diagnosis and management of PCOD by providing accurate, interpretable, and personalised care, and development of clinically interpretable models.
A. Wal, Mekala Moorthy, Rakesh Verma et al.· Current pharmaceutical desig...· 0 citations
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age and represents a major global public health challenge. PCOS is a heterogeneous condition characterized by reproductive dysfunction, hyperandrogenism, insulin resistance (IR), and metabolic...
Blessy S. Joseph, D. B, K. Kumar· International Journal of Rep...· 0 citations
Polycystic ovarian syndrome (PCOS) is a typical hormonal imbalance that affects women who are ready to procreate. In polycystic ovarian syndrome, the ovaries may generate an abundance of small fluid-filled cysts yet fail to release eggs regularly. A high amount of the male hormone produced by polycystic ovarian syndrom...
I. Barman, Sumira Malik, J. Bora et al.· Biomedical & Pharmacolog...· 0 citations
Current recommendations of the European Society of Human Reproduction and Embryology regarding the diagnosis and treatment of polyendocrine metabolic ovarian syndrome in patients with fertility disorders are summarized to demonstrate their practical application through a selected clinical case.
Soňa Šimová, L. Mekiňová, Michal Ješeta et al.· Ceska gynekologie· 0 citations
The rationale for the PCOS-to-PMOS rename is discussed, evidence linking PMOS with adverse pregnancy and offspring outcomes is reviewed, and practical implications for obstetric and gynecologic care are outlined.
M. B. Khomami, K. Hoeger, H. Huddleston et al.· American Journal of Obstetri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.